Tag

Akamai Technologies

All articles tagged with #akamai technologies

finance1 year ago•4 min saved

"Wall Street Analysts' Take on Micron's Market Performance and AI Potential"

Wall Street's top analyst calls include Stifel upgrading Micron Technology due to tightening DRAM supply, while Telsey Advisory downgrades Foot Locker citing higher spending. Other upgrades include Edwards Lifesciences, Shake Shack, and Akamai Technologies, while downgrades include Nordstrom, Victoria's Secret, Cogent, and Allient. Initiations feature Rivian Automotive, Jack Henry, Edgewise Therapeutics, MiMedx, and Despegar.com.

via Yahoo Finance|

#akamai-technologies #edwards-lifesciences #finance

business2 years ago•11 min saved

Akamai Technologies Expands Customer Base with StackPath Acquisition

Akamai Technologies has acquired select enterprise customer contracts from StackPath as StackPath discontinues its content delivery network operations. The acquisition will allow Akamai to expand its offerings and support for customers seeking enterprise solutions for content delivery, cybersecurity, and cloud computing. The transaction is expected to add approximately $20 million in revenue and be accretive to non-GAAP earnings per share by $0.03 - 0.05 for the full year in 2024. The acquisition does not include StackPath personnel or technology, and the two companies will operate under a transition services agreement for the first 90 days.

via PR Newswire|

#akamai-technologies #business #cloud-computing

business2 years ago•0 min saved

CTI BioPharma's Acquisition Sends Stock Soaring

Akamai Technologies leads S&P 500 gainers after posting better-than-expected Q1 earnings, while Rivian climbs after reporting a narrower loss and backing production guidance. Taser parent Axon slides. Other active stocks include Electronic Arts, Affirm Holdings, Marqeta, and IAC.

via MarketWatch|

#akamai-technologies #axon #business

business2 years ago•2 min saved

Stocks on the Move: Moderna, CarMax, Coinbase, and More

Shares of WW International surged 48% after Goldman Sachs upgraded the diet company to a buy from neutral rating, while CarMax's shares jumped 10% after it announced a beat on its earnings for the fourth quarter. Biotech stock Moderna lost about 4% after the company said that its flu vaccine trial fell short of the criteria for early success in a late-stage trial. Tesla gained 1% in midday trading Tuesday, implementing a slew of new price cuts on its website on Friday. Meanwhile, shares of Akamai Technologies added 2.6% the day after Piper Sandler analyst James Fish upgraded Akamai to overweight from neutral.

via CNBC|

#akamai-technologies #business #carmax